AtriCure, Inc. (ATRC)
39.78
-0.40
(-1.00%)
USD |
NASDAQ |
Dec 31, 11:35
AtriCure Cash from Investing (Quarterly): -2.605M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -457.00M |
| Alphatec Holdings, Inc. | -13.89M |
| Boston Scientific Corp. | -502.00M |
| iRhythm Technologies, Inc. | -89.20M |
| Perspective Therapeutics, Inc. | 13.99M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 26.72M |
| Cash from Financing (Quarterly) | 5.984M |
| Free Cash Flow | 31.93M |
| Free Cash Flow Per Share (Quarterly) | 0.5032 |
| Free Cash Flow to Equity (Quarterly) | 18.45M |
| Free Cash Flow to Firm (Quarterly) | 28.67M |
| Free Cash Flow Yield | 1.69% |